Thomas A. Raffin - Jun 12, 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Thomas A. Raffin, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Jun 12, 2023
Transactions value $
$10,100,000
Form type
4
Date filed
6/12/2023, 06:15 PM
Previous filing
Jun 5, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Purchase $100K +20K +9.32% $5.00 235K Jun 12, 2023 Thomas A. Raffin Living Trust dated March 29, 2017
transaction AKYA Common Stock Purchase $983K +197K +12.76% $5.00 1.74M Jun 12, 2023 See Footnote F1
transaction AKYA Common Stock Purchase $9.02M +1.8M +12.76% $5.00 15.9M Jun 12, 2023 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held directly by THP III Affiliates Fund, LLC ("THP III AFF"). Telegraph Hill Partners III Investment Management, LLC ("THP IM") is the manager of THP III AFF. Telegraph Hill Partners Management Company, LLC ("THPMC") is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III AFF. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F2 Shares held directly by Telegraph Hill Partners III, L.P. ("THP III"). THP IM is the general partner of THP III. THPMC is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.